Over the last 180 days, Tempest Therapeutics, Inc. insiders bought a net $1.0M of stock across 10 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.
Showing the most recent few. Create a free account to see 5 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| OPERATING INCOME | $-26.6M | $-42.0M | $-29.2M | $-34.6M |
| NET INCOME | $-26.3M | $-41.8M | $-29.5M | $-35.7M |
| EPS (DILUTED) | -6.33 | -19.50 | -1.91 | -3.09 |
| OPERATING CASH FLOW | $-26.8M | $-33.0M | $-27.4M | $-31.1M |
| CASH | $7.7M | $30.3M | $39.2M | $31.2M |
| LONG-TERM DEBT | — | $0 | $6.3M | $10.4M |
No password to create and no card required. We store your email address and nothing else.